Biweekly CHOP biweekly THP-COP regimen in the treatment of aggressive non-Hodgkin's lymphoma - Comparison of doxorubicin and pirarubicin: A randomized phase II study.

被引:0
|
作者
Tsurumi, H
Sawada, M
Yamada, T
Hara, T
Goto, H
Fukuno, K
Shimizu, M
Yoshikawa, T
Kanemura, N
Takahashi, T
Oyama, M
Ozawa, K
Moriwaki, H
机构
[1] Gifu Univ, Sch Med, Dept Internal Med 1, Gifu 500, Japan
[2] Kisogawa Hosp, Dept Internal Med, Kisogawa, Aichi, Japan
[3] Takayama Red Cross Hosp, Dept Internal Med, Takayama, Gifu, Japan
[4] Gifu Municipal Hosp, Dept Hematol, Gifu, Japan
[5] Jichi Med Sch, Dept Hematol, Minami Kawachi, Tochigi 32904, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1460
引用
收藏
页码:346A / 346A
页数:1
相关论文
共 50 条
  • [31] Gem-(R)CHOP Versus (R)CHOP: A Randomized Phase II Study of Gemcitabine Combined with (R)CHOP in Untreated Aggressive Non-Hodgkin's Lymphoma - EORTC Lymphoma Group Protocol 20021
    Aurer, Igor
    Eghbali, Houchingue
    Raemackers, John M.
    Khaled, Hussein M.
    Van Glabbeke, Martine
    Baila, Liliana
    van der Maazen, Richard
    [J]. BLOOD, 2008, 112 (11) : 1234 - 1235
  • [32] Response and adverse drug reactions to combination chemotherapy in elderly patients with aggressive non-Hodgkin's lymphoma: comparison of CHOP, COP-BLAM, COP-BLAM III, and THP-COPBLM
    Niitsu, N
    Umeda, M
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 1999, 63 (05) : 337 - 344
  • [33] Oral combination chemotherapy regimen for elderly patients with disseminated histologically aggressive non-Hodgkin's lymphoma (NHL): A randomized Goelams study.
    Delwail, V
    Voillat, L
    Lacotte-Thierry, L
    Le Maignan, C
    Colombat, P
    Delaunay, C
    Gardembas, M
    Casassus, P
    Lucas, V
    Dugay, J
    Guilhot, J
    [J]. BLOOD, 2000, 96 (11) : 140A - 141A
  • [34] Phase II study of rituximab in combination with CHOP chemotherapy and GMCSF in patients with previously untreated aggressive non-Hodgkin's lymphoma.
    Venugopal, P
    Gregory, SA
    Wooldridge, J
    Yunus, F
    Adler, S
    Shammo, J
    Enschede, S
    O'Brien, T
    Franson, P
    Porter, C
    [J]. BLOOD, 2002, 100 (11) : 314B - 314B
  • [35] A phase II study of a THP-COP regimen for the treatment of elderly patients aged 70 years or older with diffuse large B-cell lymphoma
    Tsurumi, Hisashi
    Hara, Takeshi
    Goto, Naoe
    Kanemura, Nobuhiro
    Kasahara, Senji
    Sawada, Michio
    Yasuda, Ichiro
    Yamada, Toshiki
    Shimizu, Masahito
    Takami, Tsuyoshi
    Moriwaki, Hisataka
    [J]. HEMATOLOGICAL ONCOLOGY, 2007, 25 (03) : 107 - 114
  • [36] Comparison of high and low doses of T-COP regimens including a new anthracyclin pirarubicin (THP), in elderly patients with non-Hodgkin's lymphoma.
    Kitamura, K
    Mori, M
    Masuda, M
    Hotta, T
    Miyazaki, T
    Miura, R
    Mizoguti, H
    Shibata, A
    Saitoh, H
    Matuda, T
    Masaoka, T
    Harada, M
    Niho, Y
    Takaku, F
    [J]. BLOOD, 1998, 92 (10) : 622A - 622A
  • [37] Biweekly THP-COPBLM (pirarubicin, cyclophosphamide, vincristine, prednisone, bleomycin and procarbazine) regimen combined with granulocyte colony-stimulating factor (G-CSF) for intermediate- and high-grade non-Hodgkin's lymphoma
    Niitsu, N
    Umeda, M
    [J]. LEUKEMIA, 1998, 12 (09) : 1457 - 1460
  • [38] Treatment of histologically aggressive non-Hodgkin's lymphoma:: Pilot study
    Chavas, M
    Bernabé, R
    Rodríguez, A
    Duque, A
    Borrega, P
    Rosillo, F
    Gómez, A
    Moreno, A
    Iglesias, L
    Moreno, JA
    [J]. EUROPEAN JOURNAL OF CANCER, 1998, 34 : S24 - S24
  • [39] Biweekly THP-COPBLM (pirarubicin, cyclophosphamide, vincristine, prednisone, bleomycin and procarbazine) regimen combined with granulocyte colony-stimulating factor (G-CSF) for intermediate- and high-grade non-Hodgkin's lymphoma
    N Niitsu
    M Umeda
    [J]. Leukemia, 1998, 12 : 1457 - 1460